@article{10956,
  keywords = {Adult, Humans, *COVID-19/epidemiology, SARS-CoV-2, Post-Acute COVID-19 Syndrome, Incidence, Cohort Studies, *Diabetes Mellitus, Type 1, Immunomodulating Agents, Primary health care, United Kingdom/epidemiology, Covid-19, Cohort study, Immune-mediated inflammatory diseases},
  author = {U. Syed and A. Subramanian and D. Wraith and J. Lord and K. McGee and K. Ghokale and K. Nirantharakumar and S. Haroon},
  title = {Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care},
  year = {2023},
  journal = {BMC Med},
  volume = {21},
  edition = {2023/09/22},
  number = {1},
  pages = {363},
  isbn = {1741-7015},
  doi = {10.1186/s12916-023-03049-5},
  note = {1741-7015
Syed, Umer
Subramanian, Anuradhaa
Wraith, David C
Lord, Janet M
McGee, Kirsty
Ghokale, Krishna
Nirantharakumar, Krishnarajah
Haroon, Shamil
DH_/Department of Health/United Kingdom
VAC_/Versus Arthritis/United Kingdom
Journal Article
Research Support, Non-U.S. Gov't
England
BMC Med. 2023 Sep 21;21(1):363. doi: 10.1186/s12916-023-03049-5.},
  language = {eng},
}